首頁 > 市場調查報告書 > 製藥

糖尿病

市場調查報告書

商品編碼

1904183

糖尿病護理設備市場規模、佔有率和成長分析（按類型、通路、最終用途和地區分類）—產業預測（2026-2033 年）

Diabetes Device Market Size, Share, and Growth Analysis, By Type (BGM Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球糖尿病護理設備市場規模將達到 362.3 億美元，到 2025 年將達到 394.2 億美元，到 2033 年將達到 774 億美元，預測期（2026-2033 年）的複合年成長率為 8.8%。

由於都市化加速和久坐生活方式的盛行，全球糖尿病負擔日益加重。許多患者如今都患有糖尿病，而糖尿病往往伴隨中風、心血管疾病、神經病變和感染疾病等嚴重的健康併發症。人們對糖尿病管理的日益重視凸顯了對旨在有效控制疾病和預防併發症的先進醫療設備的迫切需求。因此，市場對包括高階胰島素幫浦和胰島素筆在內的先進胰島素輸注系統的需求不斷成長，這反映出糖尿病照護領域正朝著創新解決方案的方向發展。領先的製造商正策略性地專注於技術進步，並開發突破性產品，以期在快速成長的糖尿病設備市場中佔據重要佔有率。

全球糖尿病設備市場促進因素

全球糖尿病患者數量的不斷成長是推動糖尿病設備市場擴張的主要動力。久坐不動的生活方式、不良飲食習慣、肥胖率上升以及人口老化等因素共同導致糖尿病患者數量快速成長。這一成長趨勢促使人們對能夠有效管理和監測糖尿病的先進設備的需求日益成長。隨著越來越多的患者尋求糖尿病管理方案，對創新設備的需求持續攀升，推動市場成長，並激勵製造商開發新技術以應對這一緊迫的醫療挑戰。

限制全球糖尿病設備市場的因素

有效的糖尿病管理高度依賴糖尿病管理設備的準確性和可靠性。然而，測量誤差、校準問題或技術故障都可能出現，進而影響設備所提供資料的可靠性。這些不準確性可能導致錯誤的治療決策，並危及病人安全。為了增強醫護人員和糖尿病患者的信任，製造商必須優先考慮設備的準確性和可靠性。提高這些因素不僅有助於有效治療，還能增強整個醫療保健系統對糖尿病管理工具的信任。

全球糖尿病設備市場趨勢

全球糖尿病設備市場正呈現將先進技術融入胰島素輸注系統的顯著趨勢，尤其是在胰島素幫浦和胰島素筆的創新方面。能夠與持續血糖監測（CGM）系統無縫整合的智慧胰島素輸注系統的出現，正在革新糖尿病管理。這些先進設備可根據即時血糖值讀數自動調整胰島素劑量，進而提高使用者的便利性和準確性。因此，患者可以受益於個人化的胰島素劑量，進而改善血糖控制和整體健康。這種技術進步正在推動市場對更聰明、更互聯的糖尿病管理解決方案的需求。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Medtronic（Ireland）
Abbott Laboratories（United States）
DexCom（United States）
Novo Nordisk（Denmark）
Becton, Dickinson and Company（United States）
Roche（Switzerland）
Insulet（United States）
Tandem Diabetes Care（United States）
Ypsomed（Switzerland）
Sanofi（France）
Eli Lilly and Company（United States）
LifeScan（United States）
F. Hoffmann-La Roche Ltd.（Switzerland）
Bayer AG（Germany）
Johnson & Johnson（United States）
Terumo Corporation（Japan）
AgaMatrix Holdings（United States）
ARKRAY USA（United States）
Nipro Corporation（Japan）

結論與建議

簡介目錄

Product Code: SQMIG35B2125

Global Diabetes Device Market size was valued at USD 36.23 Billion in 2024 and is poised to grow from USD 39.42 Billion in 2025 to USD 77.4 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026-2033).

The global burden of diabetes is intensifying, driven by increasing urbanization and sedentary lifestyles. Currently, a significant population is living with diabetes, which is often linked to serious health complications such as stroke, cardiovascular disease, nerve damage, and infections. This growing awareness of diabetes management emphasizes the necessity for advanced medical devices aimed at effective disease control and complication prevention. Consequently, there is a rising demand for sophisticated insulin delivery systems, including high-end pumps and pens, reflecting a shift towards innovative solutions in diabetes care. Leading manufacturers are strategically focusing on technological advancements and creating groundbreaking products to capture a substantial share of the burgeoning diabetes device market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetes Device Market Segments Analysis

Global Diabetes Device Market is segmented by Type, Distribution Channel, End Use and region. Based on Type, the market is segmented into BGM Devices. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies and Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetes Device Market

The increasing global prevalence of diabetes serves as a key catalyst for the expansion of the diabetes device market. A combination of factors, including sedentary lifestyles, poor dietary choices, rising obesity rates, and an aging demographic, is fueling the surge in diabetes cases. This growing incidence elevates the necessity for advanced diabetes devices designed for effective management and monitoring of the condition. As more individuals seek solutions to control their diabetes, the demand for innovative devices continues to rise, driving market growth and prompting manufacturers to develop technologies that cater to this pressing healthcare challenge.

Restraints in the Global Diabetes Device Market

The effectiveness of diabetes management heavily relies on the accuracy and reliability of diabetes devices. Unfortunately, variations in measurements, calibration challenges, or technical malfunctions can sometimes occur, undermining the dependability of the data these devices provide. Such inaccuracies can result in misguided treatment decisions, potentially jeopardizing patient safety. To foster confidence among healthcare professionals and those living with diabetes, it is imperative that manufacturers prioritize the consistent accuracy and reliability of their devices. Enhancing these factors not only supports effective treatment but also strengthens the overall trust in diabetes management tools within the healthcare ecosystem.

Market Trends of the Global Diabetes Device Market

The Global Diabetes Device market is experiencing a notable trend toward the integration of advanced technology in insulin delivery systems, particularly through innovations in insulin pumps and pens. The emergence of smart insulin delivery systems, which seamlessly connect with continuous glucose monitoring (CGM) systems, is revolutionizing diabetes management. These sophisticated devices facilitate automated insulin adjustments based on real-time glucose readings, enhancing user convenience and accuracy. As a result, patients benefit from personalized insulin delivery, leading to improved glycaemic control and overall health outcomes. This technological evolution underscores the growing demand for smarter, more interconnected diabetes management solutions in the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Diabetes Device Market Size by Type & CAGR (2026-2033)

Market Overview
BGM Devices
- Self-Monitoring Devices
- Blood Glucose Meters
- Testing Strips
- Lancets
- Continuous Glucose Monitoring Devices
- Sensors
- Transmitters
- Receiver
- Insulin Delivery Devices
- Pumps
- Pens
- Syringes
- Jet Injectors

Global Diabetes Device Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics/Centers
Online Pharmacies
Others

Global Diabetes Device Market Size by End Use & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Centers
Homecare

Global Diabetes Device Market Size & CAGR (2026-2033)

North America (Type, Distribution Channel, End Use)
- US
- Canada
Europe (Type, Distribution Channel, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Distribution Channel, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Distribution Channel, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Distribution Channel, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DexCom (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeScan (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgaMatrix Holdings (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARKRAY USA (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments